Need Help?
Announcements
14 May 2026
Meet Us at the ncRNA2026: From Molecular Mechanisms to Clinical Impact, 24–26 June 2026, Leuven, Belgium
MDPI will be attending the international conference “ncRNA2026: From Molecular Mechanisms to Clinical Impact” in Leuven, Belgium, which will take place from 24 to 26 June 2026. In recent years, non-coding RNA studies have revolutionized our understanding of gene regulation, cellular networks, and disease mechanisms. ncRNA2026 will showcase the latest breakthroughs in ncRNA biology and technology through a program dedicated entirely to this field—from molecular mechanisms and clinical applications to data science and translational insights. The conference will feature distinguished international invited speakers, complemented by a strong selection of oral and poster presentations from submitted abstracts.
The following MDPI journals will be represented:
- Non-Coding RNA;
- Applied Biosciences;
- BioMed;
- BioMedInformatics;
- Biomolecules;
- Cells;
- Current Issues in Molecular Biology (CIMB);
- Current Oncology;
- Diagnostics;
- Epigenomes;
- International Journal of Molecular Sciences (IJMS);
- Targets.
If you are attending the conference, please feel free to visit our booth. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following link: https://sciforum.net/event/ncRNA2026.
6 May 2026
Head and Neck Cancer Awareness Month, April 2026
As part of its continued efforts to support impactful cancer research and foster scientific dialogue, MDPI is spotlighting head and neck cancer in this edition. Encompassing a diverse group of malignancies affecting the oral cavity, pharynx, and larynx, head and neck cancers collectively account for over 900,000 new cases and more than 400,000 deaths globally each year.
In recent years, shifting epidemiological patterns, particularly the rise of HPV-associated cancers, have introduced new challenges and opportunities in both research and clinical practice. These developments call for deeper insights into disease mechanisms, as well as more precise approaches to diagnosis, treatment, and patient stratification.
By bringing together cutting-edge research, focused Special Issues, and an expert-led webinar, MDPI journals aim to continue to facilitate knowledge exchange and highlight emerging advances in the field. These efforts play an important role in advancing innovation, improving early detection and therapeutic strategies, and ultimately enhancing outcomes for patients worldwide.

![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |

|
Keynote speakers |
||
![]() |
![]() |
![]() |
|
Dr. Kousik Kumar Kesh, |
Prof. Dr. Richard Yuxiong Su, |
Dr. Jennifer Anderson, |
![]() |
![]() |
![]() |
|
Dr. Jay J. Liao, |
Prof. Dr. Wendell G. Yarbrough, |
Dr. Joshua D. Smith, |
Register for this webinar for free here!

“Enhancing Patient Outcomes in Head and Neck Cancer Radiotherapy: Integration of Electronic Patient-Reported Outcomes and Artificial Intelligence-Driven Oncology Care Using Large Language Models”
by ChihYing Liao, ChinNan Chu, TingChun Lin, TzuYao Chou and MengHsiun Tsai
Cancers 2025, 17(14), 2345; https://doi.org/10.3390/cancers17142345
“Advancing Head and Neck Cancer Therapies: From Conventional Treatments to Emerging Strategies”
by Aleksandra Mordzińska-Rak, Ilona Telejko, Grzegorz Adamczuk, Tomasz Trombik, Andrzej Stepulak and Ewa Błaszczak
Biomedicines 2025, 13(5), 1046; https://doi.org/10.3390/biomedicines13051046
“The Role of Dysphagia on Head and Neck Cancer Patients’ Quality of Life, Functional Disabilities and Psychological Distress: Outcomes of Cancer Rehabilitation from an Observational Single-Center Study”
by Špela Matko, Christina Knauseder, David Riedl, Vincent Grote, Michael J. Fischer, Samuel Moritz Vorbach, Karin Pfaller-Frank, Wilhelm Frank and Thomas Licht
Curr. Oncol. 2025, 32(4), 220; https://doi.org/10.3390/curroncol32040220
“PDLIM3 Regulates Migration and Invasion of Head and Neck Squamous Cell Carcinoma via YAP–Mediated Epithelial–Mesenchymal Transition”
by Fan Yang, Ying Zhou, You Zhang, Weideng Wei, Fei Huang, Dan Yang, Yixin Zhang, Ruiyang Zhang, Xiaoqiang Xia, Qianming Chen et al.
Int. J. Mol. Sci. 2025, 26(7), 3147; https://doi.org/10.3390/ijms26073147
“Inflammatory Biomarkers and Oral Health Disorders as Predictors of Head and Neck Cancer: A Retrospective Longitudinal Study”
by Amr Sayed Ghanem, Kitti Sipos, Ágnes Tóth and Attila Csaba Nagy
Int. J. Mol. Sci. 2025, 26(5), 2279; https://doi.org/10.3390/ijms26052279
“Trends in Incidence and Mortality of Head and Neck Cancer Subsites Among Elderly Patients: A Population-Based Analysis”
by Małgorzata Wierzbicka, Wioletta Pietruszewska, Adam Maciejczyk and Jarosław Markowski
Cancers 2025, 17(3), 548; https://doi.org/10.3390/cancers17030548
“Recurrent and Metastatic Head and Neck Cancer: Mechanisms of Treatment Failure, Treatment Paradigms, and New Horizons”
by William T. Barham, Marshall Patrick Stagg, Rula Mualla, Michael DiLeo and Sagar Kansara
Cancers 2025, 17(1), 144; https://doi.org/10.3390/cancers17010144
“Identification of Biomarkers for Diagnosis and Prognosis of Head and Neck Cancer: Bioinformatics Approach”
by Alexandra Fernandes and Rui Vitorino
Targets 2024, 2(4), 470-480; https://doi.org/10.3390/targets2040026
“Clinical Evidence of Methods and Timing of Proper Follow-Up for Head and Neck Cancers”
by Riccardo Gili, Simone Caprioli, Paola Lovino Camerino, Gianluca Sacco, Tommaso Ruelle, Daria Maria Filippini, Silvia Pamparino, Stefania Vecchio, Filippo Marchi, Lucia Del Mastro et al.
Onco 2024, 4(4), 275-286; https://doi.org/10.3390/onco4040020
“Artificial Intelligence in Head and Neck Cancer: Innovations, Applications, and Future Directions”
by Tuan D. Pham, Muy-Teck Teh, Domniki Chatzopoulou, Simon Holmes and Paul Coulthard
Curr. Oncol. 2024, 31(9), 5255-5290; https://doi.org/10.3390/curroncol31090389
|
“The Advances in Proton Therapy in Head-and-Neck Cancers” |
“Decoding and Remodeling the Suppressive Tumor Immune Microenvironment in Head and Neck Cancer” |
![]() |
![]() |
|
“The Role of Targeted Therapy in Head and Neck Cancers” |
“Molecular Targets for HPV-Related Head and Neck Cancer” |
![]() |
![]() |
|
“Head and Neck Cancer: From Mechanisms to Therapeutic Approaches—Advances and Challenges” |
“Targeting Head and Neck Cancer: From Tumor Microenvironment to Therapy Resistance” |
![]() |
![]() |

![]() |
![]() |
![]() |
6 May 2026
MDPI INSIGHTS: The CEO's Letter #34 - MDPI US Office, Coatings 2026, Media and Partnerships, Recapping Poland Summit & Serbia Salon
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts

MDPI Opens First US Office in Philadelphia
I am delighted to highlight an important milestone in MDPI’s continued global development: the recent opening of our first office in the United States, located in Philadelphia.
This marks a significant step in building our engagement with one of the world’s most important research communities. The new office will serve as a hub for supporting scholars across the US, creating closer connections and more localized support.
As highlighted in recent coverage by our press release in InPublishing, this expansion reflects MDPI’s broader commitment to growing our international presence while remaining focused on the needs of the research community.
A Key Market for Research and Collaboration
The United States continues to play a central role in global research. To date, MDPI has published more than 237,000 articles affiliated with US institutions, and we collaborate with nearly 12,000 Editorial Board Members across the country. These relationships are fundamental to our mission of supporting Open Access and advancing scientific communication.
The opening of this office is not just about geography; it is about proximity to the communities we serve. It allows us to better understand the evolving needs of researchers while continuing to build collaboration and trust within the academic ecosystem.
The Team Behind this Milestone

This milestone reflects the efforts of teams across MDPI. I extend a special thank-you to Bob Vrooman (Head of Business Development, MDPI), who is leading this expansion, as well as to our colleagues in Toronto and across our North American teams for their continued support.
Bob shared: “MDPI is already a trusted partner of the North American research community, due in no small part to our dedicated team in Canada. Launching our first US office in Philadelphia is a great first step towards expanding MDPI’s market share and recognition in the US. I’m thrilled to be a part of this new phase in MDPI’s journey.”
As we continue to grow, our focus remains on supporting researchers globally and advancing Open Access with integrity.
Impactful Research

Coatings 2026: Highlights from Our Latest MDPI Conference (20-22 April)
I am pleased to share the successful completion of MDPI conference Coatings 2026, which took place last week in Athens from 20 to 22 April 2026. This conference brought together a diverse international community of researchers, industry experts, and partners, highlighting MDPI’s role not only as a publisher but also as a platform for scientific exchange and collaboration.
Conference Highlights
Coatings 2026 in numbers:
- The event attracted approximately 140 participants from 25 countries
- 143 submissions and a strong scientific program of talks and posters
- 2 keynote speakers and a wide range of invited contributions
- 7 sponsors and 11 media partners supporting the event
|
|
|
|
|
|
Scientific Programme
The program centered on “Safe and Sustainable by Design,” reflecting the growing importance of sustainability, regulatory frameworks, and technological innovation in materials science. Topics ranged from advanced coating technologies and additive manufacturing to AI-driven simulations and strategies to phase out potentially harmful substances in industrial processes.
Importantly, the conference brought together both academic and industrial perspectives, creating a space for dialogue on how research can translate into real-world impact. This is important as industries navigate environmental challenges, evolving regulations, and the need for more sustainable and circular approaches to production.
Thank You!
I would like to thank the entire conference team for their work in organizing this successful event. As we continue to grow, conferences like this play an important role in building our connection with global research communities, supporting interdisciplinary collaboration, and positioning MDPI at the intersection of science, technology, and societal impact.
Members from Exelisis and MDPI EU Conference & Social Media team at the Coatings 2026 Conference in Athens, Greece.
Inside MDPI

Recent Media Coverage and Partnerships
Over the past two months, news from MDPI has enjoyed strong visibility across international publishing and academic media, reflecting our continued expansion and the increasing relevance of our work within the research community.
Below are some highlights covering partnerships, institutional agreements, and milestones that continue to shape our position in publishing – some of which are featured in leading industry platforms such as InPublishing, which is highly selective and reflects the growing recognition of MDPI’s growth within the publishing ecosystem.
Key Press Releases & Coverage (March–April 2026)
-
MDPI × Sikt (Norway): Partnership Renewal
We renewed our national Open Access agreement with Sikt, a key consortium partnership, continuing to support researchers across Norway through this partnership. The renewal was covered by several international publishing trade outlets.
Covered by: Research Information, STM Publishing News, ALPSP, Europe Says
-
MDPI × Jisc (UK): New Two-Year Open Access Agreement
A new two-year agreement with Jisc significantly expands MDPI’s footprint across UK academic institutions. Coverage appeared across major publishing industry titles in the UK and internationally.
Covered by: InPublishing, Research Information, STM Publishing News, ALPSP
-
MDPI Opens First US Office
The opening of our first US office marks an important milestone in our North American expansion to build engagement with one of the world’s leading research communities.
Coverage by: EurekAlert!, InPublishing, EdTech Innovation Hub, STM Publishing News, ALPSP
-
MDPI × SIGG: Italian Society of Gerontology and Geriatrics
We established a new partnership with the Italian Society of Gerontology and Geriatrics (SIGG), adding to our growing portfolio of society collaborations.
Coverage by: EurekAlert!, STM Publishing News, ALPSP
-
MDPI × Fast Track Health: New Journal Launch
The launch of a new journal in partnership with Fast Track Health reflects our continued expansion into emerging areas of health innovation.
Coverage by: EurekAlert!, Scienmag, STM Publishing News, ALPSP
-
MDPI 2025 Annual Report
Our 2025 Annual Report was also widely covered across international media, highlighting a 12% increase in submissions and continued investment in research integrity, infrastructure, and partnerships.
Coverage by: EurekAlert!, Research Information, STM Publishing News, ALPSP, Choice 360
Coverage also spanned multiple regions including Poland, Romania and South Korea, reflecting our ongoing efforts to communicate more effectively with regional research communities.
Looking Ahead
This coverage shows that MDPI is growing and building on its position through partnerships, visibility, and engagement across regions. As we continue to expand, our focus remains on supporting researchers globally, building on our institutional collaborations, and advancing Open Access with integrity.
Thank you to all teams involved in delivering these initiatives, and to our External Affairs team for ensuring our work is effectively communicated across the global publishing landscape!
Coming Together for Science

Recapping MDPI Poland Summit 2026 in Krakow (23 April)
On 23 April 2206, we hosted the first MDPI Poland Summit 2026 in Kraków, bringing together an engaged group of editors, researchers, and academic leaders from the country.
The Poland Summit welcomed some 45 participants, including Editors-in-Chief, Associate Editors, and Editorial Board Members, many with strong academic track records and international recognition.
Our engagements were open and constructive, focusing on MDPI’s positioning and reputation in Poland, alongside community interest in supporting our development, with active participation across our sessions, including Q&A and panel discussions.
|
|
|
|
MDPI Poland Summit Programme
From research integrity and peer review quality to AI in publishing and the future of academic communication, the agenda featured important topics currently shaping our industry.
During the day, MDPI colleagues shared a series of presentations covering:
- MDPI’s performance, growth, and impact in Poland: Stefan Tochev (CEO)
- Engagement with Academic Community: Dr. Marta Colomer (Public Affairs Lead)
- Research Integrity and Publication Ethics: Anna Pena (Research Integrity Manager)
- MDPI Editorial Process and Peer-Review Quality Metrics: Dr. Liliane Auwerter (Conference Organizer)
- AI in the Publishing Industry – Challenges, Innovation and MDPI’s vision: Dr. Enric Sayas (AI Product Owner)
- Panel Session: The Future of Academic Publishing, moderated by Dr. Marta Colomer
|
|
|
|
|
|
|
|
Poland as a Key Market for Open Access
The summit also highlighted the importance of Poland within the global research landscape.
In 2025:
- 75% of publications in Poland were made in Open Access
- 71% of those in Gold Open Access
- and over 344,000 publications produced in the last five years
MDPI plays a significant role in the Polish publishing ecosystem:
- #1 Open Access publisher in Poland
- 17% share of Open Access publications in 2025
- More than 12,500 publications from Polish institutions in 2025
- More than 91,000 publications overall since 1996
Looking Ahead
Events like the Poland Summit are an important part of how we evolve as an organization. They allow us to share the latest developments of MDPI and listen directly to our researchers and editors to better understand the market and align our development with the needs of the local community.
As MDPI continues to grow, this type of engagement will remain essential in ensuring that we are not only scaling globally, but doing so in a way that is aligned, trusted, and collaborative.

With Igor Matic (Office Manager, Krakow, Poland, MDPI) at the MDPI Poland Summit in Krakow.
Closing Thoughts

Recapping MDPI Serbia Salon 2026 in Belgrade (22 April)
On 22 April 2026, we hosted the MDPI Serbia Salon 2026 in Belgrade. The Salon welcomed over 50 participants, including more than 40 invited scholars from leading Serbian institutions, alongside colleagues from MDPI. The event also marked two important milestones: 30 years of MDPI and 10 years of our presence in Serbia, making it a celebration and an opportunity for reflection.

A Platform for Exchange
The Salon was designed not just as a series of presentations, but as a place for dialogue. Throughout the day, discussions focused on important topics around publishing today: research integrity and editorial standards, journal indexing and visibility, the evolving role of artificial intelligence, and funding and support for Open Access publishing.
|
|
|
|
|
|
|
|
Program Overview
- Opening the Salon MDPI Serbia 2026 – Serbia results and direction: Emir Ramadani (Operations Manager)
- Update on MDPI’s performance and growth: Stefan Tochev (CEO)
- Collaboration with MDPI – A personal perspective: Prof. Dr Srećko Stopić (Editorial Board Member)
- Linking Scientific Quality and Visibility: The role of indexing in publishing
- Research integrity and editorial ethics: Ana Stanković (Research Integrity Specialist)
- Artificial Intelligence in Scientific Publishing – Challenges, innovations and vision of MDPI: Dr Miloš Čučulović (Head of Technology Innovation)
It was encouraging to see the high level of engagement and discussion with the local academic community.
|
|
|
|
|
|
|
|
Publishing in Serbia
With 10 years of MDPI in Serbia (since 2016) and over 620 colleagues across 10 departments spread across offices in Belgrade and Novi Sad, MDPI continues to invest in the long-term development of the research community in Serbia and beyond.
Some high-level indicators illustrate both the strength of the local research ecosystem and MDPI’s role within it:
- 12,910 total publications in Serbia in 2025, of which 8,708 (67%) were Open Access (of which, in turn, 75% were Gold OA)
- A total of more than 55,000 publications (2021–2025), with 68% published Open Access
- 2,122 MDPI publications from Serbian institutions in 2025
- 25% of all Open Access publications in Serbia are published with MDPI
- More than 11,000 MDPI publications from Serbian institutions since 1996
- More than 75 Editorial Board Members from Serbia, including Editors-in-Chief and Associate Editors.
These figures reflect the growth of OA publishing in Serbia and the strong collaboration between MDPI and Serbia's research community.
Top 5 Publishers in Serbia (MDPI #1 with steady growth)

Looking Ahead
Research integrity and artificial intelligence will remain central topics for the industry. At the same time, clear communication of editorial processes will be essential in building trust and transparency.
Workshops and direct engagement remain among the most effective ways to strengthen these connections. As Open Access funding models continue to evolve, new opportunities for collaboration are emerging across institutions, publishers, and the broader research community.
Thank You!
The excellent feedback from participants shows the value of creating spaces where ideas can be exchanged openly and constructively. Sincere thanks to everyone who contributed to the success of this event: our speakers, participants, and especially the MDPI Serbia team for their great organization and support.

Chief Executive Officer
MDPI AG
27 April 2026
MDPI World Cancer Day Webinar | April—Head and Neck Cancer Awareness Month, 30 April 2026
To commemorate World Cancer Day 2026, MDPI is pleased to introduce the “World Cancer Day 2026 Webinar Series”. Reflecting the global theme “United by Unique”, this series highlights how every story, discovery, and voice contributes to strengthening the global fight against cancer.
In our April session, we welcome leading voices in head and neck cancer research to share impactful insights, raise awareness, and highlight recent advances in prevention, diagnosis, and treatment.
Through this series, we aim to empower the global community with knowledge, inspire collaboration, and support ongoing efforts to address cancer worldwide. Together, we honor every patient’s journey, recognize every researcher’s contribution, and reinforce the power of collective action in the fight against cancer.
Date: 30 April 2026
Time: 17:00 CEST | 11:00 EDT | 23:00 CST Asia
Webinar ID: 824 5069 5488
Webinar Secretariat: journal.webinar@mdpi.com
Website: https://sciforum.net/event/WCD2026-3
Register now for free!
| Speaker | Presentation | Time (CEST) | Time (EDT) |
| Introduction | 17:00–17:10 | 11:00–11:10 | |
| Dr. Kousik Kesh | TBC | 17:10–17:30 | 11:10–11:30 |
| Q&A Session | 17:30–17:35 | 11:30–11:35 | |
| Prof. Dr. Richard Su | Artificial Intelligence in Oral Cancer Risk Prediction | 17:35–17:55 | 11:35–11:55 |
| Q&A Session | 17:55–18:00 | 11:55–12:00 | |
| Dr. Jennifer Anderson | Liposomal Doxorubicin Potentiates Anti-Tumor Immune Response in Head and Neck Squamous Cell Carcinoma | 18:00–18:20 | 12:00–12:20 |
| Q&A Session | 18:20–18:25 | 12:20–12:25 | |
| Dr. Jay Liao | Particle Beam Radiation Therapy for Head and Neck Cancer: Current Experience at The University of Washington / Fred Hutchinson Cancer Center | 18:25–18:45 | 12:25–12:45 |
| Q&A Session | 18:45–18:50 | 12:45–12:50 | |
| Dr. Wendell Yarbrough | TBC | 18:50–19:10 | 12:50–13:10 |
| Q&A Session | 19:10–19:15 | 13:10–13:15 | |
| Dr. Joshua D Smith | Mechanisms of Tobacco-Mediated Immunosuppression in Patients with HPV+ Oropharynx Cancer Who Smoke | 19:15–19:35 | 13:15–13:35 |
| Q&A Session | 19:35–19:40 | 13:35–13:40 | |
| Joint Q&A Session | 19:40–19:55 | 13:40–13:55 | |
| Closing of Webinar | 19:55–20:00 | 13:55–14:00 |
After registering, you will receive a confirmation email on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.
Unable to attend? Register anyway, and we will let you know when the recording is available for viewing.
Webinar Keynote Speakers:
- Dr. Kousik Kumar Kesh, Department of Pathology, St. Louis University, USA;
- Dr. Richard Yuxiong Su, Division of Oral and Maxillofacial Surgery, The University of Hong Kong, Hong Kong S.A.R, China;
- Dr. Jennifer Anderson, MD Anderson Cancer Center, University of Texas, USA;
- Dr. Jay J. Liao, Fred Hutchinson Cancer Center, Department of Radiation Oncology, University of Washington Medical Center, USA;
- Dr. Wendell G. Yarbrough, Department of Otolaryngology (Head and Neck Surgery), School of Medicine, University of North Carolina, USA;
- Dr. Joshua D. Smith, Department of Otolaryngology (Head and Neck Surgery), University of Pittsburgh Medical Center, USA.
24 April 2026
Prof. Dr. William Gerwick Appointed Chair of the 2026 Tu Youyou Award Committee
We are honored to announce that Prof. Dr. William Gerwick will serve as the Chair of the 2026 Tu Youyou Award Committee.
A world-renowned authority in marine natural products chemistry and pharmacology, Professor Gerwick is a Distinguished Professor at both the Scripps Institution of Oceanography and the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California San Diego (UCSD). His pioneering work at the intersection of ocean sciences and drug discovery makes him a fitting leader for an award centered on transformative medicinal breakthroughs.
Under Professor Gerwick’s stewardship, the 2026 Tu Youyou Award Committee will focus on recognizing innovative and impactful research in natural products chemistry and medicinal chemistry, particularly work with the potential to drive meaningful advances in both scientific understanding and human health.
To provide further insight into his perspectives, we include below an interview with Professor Gerwick, in which he reflects on his scientific journey, his views on the field, and his vision for the Tu Youyou Award.
A Conversation with the Chair
1. Could you please introduce yourself and your research journey?
My research focuses on the natural products of marine algae and cyanobacteria, their application in medicine, their biosynthesis using genomic approaches, and innovative methods in the structure elucidation of natural products.
I received my BS degree from the University of California at Davis, my PhD from the University of California at San Diego, and conducted postdoctoral work at the University of Connecticut. After a couple of years in a junior faculty position at the Department of Chemistry at the University of Puerto Rico, I spent 21 years as Professor of Pharmacy at Oregon State University. In 2005, I returned to my PhD institution at the Scripps Institution of Oceanography and the Skaggs School of Pharmacy and Pharmaceutical Sciences at UC San Diego, where I am currently a Distinguished Professor of Oceanography and Pharmaceutical Sciences.
Throughout my career, I have been dedicated to advancing the field through both leadership and mentorship. I have served as president of the American Society of Pharmacognosy, chaired and co-chaired several major research conferences, and served as an associate editor for the Journal of Natural Products. I am a Fellow of the American Association for the Advancement of Science (AAAS) and of the American Society of Pharmacognosy. I have trained over 100 doctoral and postdoctoral students, and my research group has published nearly 500 papers and more than 25 patents on topics in the natural product sciences and medicinal chemistry.
2. What motivated you to accept the role of Chair of the 2026 Tu Youyou Award Committee?
Of course, I am a huge supporter of all awards that are given in recognition of excellent scientific research, and especially so in the natural products sciences and medicinal chemistry. However, this award is truly special in that it recognizes scientific excellence as well as impact, and is given in the name of an individual, Tu Youyou, who clearly had many challenges along the path to reach the pinnacle of her success. Not only was she the first Chinese person to win a Nobel prize in this area, but she was also the first Chinese woman to receive a Nobel prize, and this was achieved without graduate education in China or elsewhere. It’s a true testament to what can be achieved by hard work, determination, and vision. To read the history of her extraordinary approach to discovering novel antimalarial compounds from Traditional Chinese Medicine is truly inspirational. It is, therefore, the inspiration provided by the extraordinary life and career of Tu Youyou that motivated me to accept the Chair of the Award Committee for 2026.
3. How do you view the role of natural products chemistry and medicinal chemistry in today’s scientific landscape, and what major advances over the past decade have shaped this field?
A quite remarkable integration of fields is currently transforming natural products science and medicinal chemistry. In natural products, we are seeing integration of different omics methods, from metabolites to proteins to nucleic acids. Sophisticated biological and pharmacological approaches are driving the discovery of exquisitely potent and selective natural products. Advances are being made to integrate molecular-level recognition of natural products with chemical ecological studies, and sophisticated methods of structure determination using Artificial Intelligence or pioneering new tools such as microED are being applied with increasing frequency. High-level synthetic methodologies, such as protecting group-free synthetic routes, are enhancing medicinal chemistry, accelerating the identification of lead molecules with attractive pharmaceutical properties at an increasing pace.
4. How do you consider the balance between fundamental discovery (e.g., new molecules or mechanisms) and practical impact (e.g., therapeutic applications)?
Many individuals are excellent scientists and mentors, and have essential roles in developing our culture that values science and the scientific method. It should also be pointed out that not all scientific discoveries are going to have a broad societal impact, but they are nevertheless critical to the overall body and structure of science. But it is a truly remarkable individual who makes a key scientific discovery, recognizes its potential value to society in general, and then has the skills and determination to bring it forward as a useful product. That was the type of person the Tu Youyou is, and that is the type of person who is honored by the prize in her name.
5. What do you see as the key challenges or opportunities currently facing the field?
We are on the crux of an amazing revolution in many of the sciences, including natural products and medicinal chemistry; the purposeful application of Artificial Intelligence to solving many of the difficulties involved in the search for new pharmaceuticals from Nature. AI is transforming how we select organisms for study, what pharmaceutical targets to go after, rapidly resolving the chemical structures of new compounds, identifying efficient routes to their chemical synthesis, understanding their molecular mechanisms of action, and finally, designing their clinical application. The role of people in these pursuits is changing. Increasingly, the human role will be providing overall vision: what can we do? What should we do? And it is important to remember that AI is providing hypotheses, not truth. Scientists with expert domain knowledge will be critical for discerning the correctness of hypotheses put forth by AI. Altogether, advances in technology, expanding knowledge, and the appropriate use of AI methods are preparing society to be able to address emerging diseases, such as pandemics, as well as conditions that are not effectively treated by currently existing therapeutics.
6. How do you expect the Tu Youyou Award to contribute to the advancement of natural product chemistry, medicinal chemistry, and human health over the coming years?
The Tu Youyou Award is potentially transformative for the broad fields of natural products science and medicinal chemistry as it brings a significantly increased level of visibility to these topics and their contributions to human health. It will be crucial to have excellent communication to news agencies, social media and other communication outlets so that the general public is informed and educated on the high impact of these natural product/medicinal chemistry contributions. This will bring increased funding, attract promising students, and generally enrich the interface of these fields with the health sector.
7. What message would you like to convey to the research community and the public during this open nomination phase?
This prize gives broad societal visibility to the role that natural products have had in shaping a majority of our current medicines, as well as understanding the life forms with whom we share the planet. Further, it recognizes a woman scientist working under sub-optimal conditions who could persevere and make discoveries of global impact. The prize and what it represents, therefore, inspires current and future generations to engage in the study of Nature and its relationship to Human Health, to overcome adversity, and to aspire to making one’s life impactful.
About the Tu Youyou Award
Established in 2016, the Tu Youyou Award seeks to honor those who excel in the fields of natural products chemistry and medicinal chemistry. This award offers a total prize of CHF 100,000, which will be equally divided among the winners if there is more than one, with each recipient receiving an award medal and a certificate.
The 2026 Tu Youyou Award is open for nominations until 31 October 2026. We encourage all eligible candidates to participate in this prestigious recognition, as this award not only honors individual achievement but also encourages further scientific exchange, exploration and discovery in critical areas of medicine.
If you are interested in participating, please visit the Tu Youyou Award website for more information on the nomination requirements.
16 April 2026
MDPI’s Newly Launched Journals in the First Quarter of 2026
Our portfolio of journals available for publishing up-to-date research in immediate open access format has been further expanded. In the first quarter of 2026, nine new journals released their inaugural issues and three transferred journals released their first issue as part of MDPI, covering the subjects of clinical medicine, chemistry, computer science & mathematics, engineering, environment & ecology, and social sciences & psychology.
We extend our gratitude to the Editors-in-Chief, Associate Editors, and Editorial Board Members who will shape the future course of these brand-new journals. Each journal is dedicated to upholding strong editorial standards through a thorough peer review process, ensuring impactful open access scholarship.
Please feel free to browse and discover more about the new journals below.
|
New Journals |
Founding Editor(s)-in-Chief |
Journal Topics (Selected) |
|
Prof. Dr. Matt Oehlschlaeger, |
AI-based chemical data analysis, prediction, and discovery; AI-enabled chemical reaction prediction, synthesis planning, and retrosynthesis; AI in bioorganic chemistry and chemical biology; digital twins and simulation of chemical processes; AI-powered chemical education and pedagogy | |
|
|
Prof. Dr. Guang Jia, |
occupational hazards and exposure science; occupational health effects and susceptibility; occupational risk assessment and management; occupational health intervention, promotion, and policy | |
|
|
Prof. Dr. Alessandro Miani, |
environmental exposures and health; the built environment and public health; One Health approach; environmental justice and health equity; environmental policies and interventions | |
|
|
Prof. Dr. Miriam H. A. Bopp, |
neuroimaging technology and tool; multimodal neuroimaging integration and analysis; |
|
|
Prof. Dr. Raul A. Urrutia, |
personalized translational and clinical oncology research that contribute to a deeper understanding of cancer diagnoses, prognoses, prevention, and treatment specifically for individual patients | |
|
|
Prof. Dr. Pierre Boulanger, |
AI in disease detection, diagnosis, prediction, and treatment; medical informatics; AI in genomics and precision medicine; AI in drug discovery and development; |
|
|
Prof. Dr. Zhaokui Wang, |
astrodynamics; spacecraft technology; satellite technology; space transportation; space vehicle design, propulsion, and avionics; space energy, power and propulsion | |
|
|
Prof. Dr. Richard J Hauer, |
park design, planning, and evaluation; park and art; park, industrialization, urbanization, and civilization; park and education; park and smart society; park role in SDGs; park services for humans | |
|
|
Prof. Dr. Stacey L. Connaughton, |
conflict resolution; peacebuilding; peacemaking; mediation, reconciliation, and transitional justice; sustaining peace | |
|
Transferred Journals |
Editor(s)-in-Chief |
Journal Topics (Selected) |
|
Prof. Dr. Gianluigi Vendemiale, |
physiology and pathology of aging; biogerontology; epidemiology; clinical geriatrics; pharmacology; geriatric nursing | |
|
|
Prof. Dr. Michele Maffia, |
cellular and developmental biology; physiology, pathophysiology and endocrinology; diagnostic tools, therapies and public health | |
|
|
Dr. Warren S. Joseph, |
foot and ankle medicine; podiatric medicine | |
We would like to thank everyone who has supported the development of open access publishing. If you would like to create a new journal, you are welcome to send an application here or contact the New Journal Committee (newjournal-committee@mdpi.com).
3 April 2026
Colorectal Cancer Awareness Month–March 2026
As part of its ongoing commitment to advancing cancer research and knowledge exchange, MDPI highlights colorectal cancer in the March edition—one of the most prevalent and deadly cancers worldwide. It ranks as the third most diagnosed cancer and the second leading cause of cancer-related deaths globally, with an estimated 1.9 million new cases and over 900,000 deaths each year.
Of growing concern is the steady rise in incidence among individuals under 50, a trend observed over the past two to three decades. This underscores the urgent need to better understand underlying risk factors, strengthen early detection strategies, and develop innovative diagnostic tools.
Through curated research, Special Issues, and expert-led webinars, MDPI journals continue to support collaboration across researchers, clinicians, and policymakers. Such collective efforts are essential to accelerate discoveries and translate them into meaningful action—advancing toward more effective prevention, earlier detection, and improved patient outcomes.

![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |

| Keynote Speakers | |||
![]() |
![]() |
![]() |
![]() |
| Prof. Dr. Paola Patrignani, “G. d’Annunzio” University School of Medicine, Italy |
Prof. Dr. William Gmeiner, Wake Forest University, USA |
Dr. Eva Martínez-Balibrea, |
Dr. Zoltán Wiener, Semmelweis University, Hungary |
Register for this webinar for free here!

“Integrative Mechanistic Investigation of the Anticancer Effects of Panax notoginseng in Colorectal Cancer”
by Jaemoo Chun, Sarah Shin and Jeeyoun Jung
Molecules 2026, 31(5), 807; https://doi.org/10.3390/molecules31050807
“Integrated Multi-Omics Analysis Identifies Novel Prognostic and Diagnostic Hub Genes in Colorectal Cancer”
by Devi Lal and Himani Pandey
Onco 2025, 5(4), 50; https://doi.org/10.3390/onco5040050
“A Multimodal MRI-Based Model for Colorectal Liver Metastasis Prediction: Integrating Radiomics, Deep Learning, and Clinical Features with SHAP Interpretation”
by Xin Yan, Furui Duan, Lu Chen, Runhong Wang, Kexin Li, Qiao Sun and Kuang Fuby Xin Yan, Furui Duan, Lu Chen, Runhong Wang, Kexin Li, Qiao Sun and Kuang Fu
Curr. Oncol. 2025, 32(8), 431; https://doi.org/10.3390/curroncol32080431
“Exploring Experimental Models of Colorectal Cancer: A Critical Appraisal from 2D Cell Systems to Organoids, Humanized Mouse Avatars, Organ-on-Chip, CRISPR Engineering, and AI-Driven Platforms—Challenges and Opportunities for Translational Precision Oncology”
by Ahad Al-Kabani, Bintul Huda, Jewel Haddad, Maryam Yousuf, Farida Bhurka, Faika Ajaz, Rajashree Patnaik, Shirin Jannati and Yajnavalka Banerjee
Cancers 2025, 17(13), 2163; https://doi.org/10.3390/cancers17132163
“The Gut Microbiota and Colorectal Cancer: Understanding the Link and Exploring Therapeutic Interventions”
by Imen Zalila-Kolsi, Dhoha Dhieb, Hussam A. Osman and Hadjer Mekideche
Biology 2025, 14(3), 251; https://doi.org/10.3390/biology14030251
“A Novel Bacteriophage with the Potential to Inhibit Fusobacterium nucleatum-Induced Proliferation of Colorectal Cancer Cells”
by Ho Yin Pekkle Lam, Meng-Jiun Lai, Pin-Chun Wang, Wen-Jui Wu, Li-Kuang Chen, Hsiang-Wei Fan, Chun-Chieh Tseng, Shih-Yi Peng and Kai-Chih Chang
Antibiotics 2025, 14(1), 45; https://doi.org/10.3390/antibiotics14010045
“A New Blood-Based Epigenetic Diagnostic Biomarker Test (EpiSwitch®® NST) with High Sensitivity and Positive Predictive Value for Colorectal Cancer and Precancerous Polyps”
by Ewan Hunter, Heba Alshaker, Cicely Weston, Mutaz Issa, Shekinah Bautista, Abel Gebregzabhar, Anya Virdi, Ann Dring, Ryan Powell, Jayne Green et al.
Cancers 2025, 17(3), 521; https://doi.org/10.3390/cancers17030521
“The Role of KRAS Mutations in Colorectal Cancer: Biological Insights, Clinical Implications, and Future Therapeutic Perspectives”
by Mitsunobu Takeda, Shoma Yoshida, Takuya Inoue, Yuki Sekido, Tsuyoshi Hata, Atsushi Hamabe, Takayuki Ogino, Norikatsu Miyoshi, Mamoru Uemura, Hirofumi Yamamoto, Yuichiro Doki and Hidetoshi Eguchi
Cancers 2025, 17(3), 428; https://doi.org/10.3390/cancers17030428
“Network Pharmacology and Bioinformatics Study of Six Medicinal Food Homologous Plants Against Colorectal Cancer”
by Xinyue Zhao, Jian Xiu, Hengzheng Yang, Weiwei Han and Yue Jin
Int. J. Mol. Sci. 2025, 26(3), 930; https://doi.org/10.3390/ijms26030930
“A Review of Potential Agents for Colon Cancer Interception in FAP Patients: Evidence from Preclinical Studies in APCMin/+ Mice”
by Karthikkumar Venkatachalam, Krishnendu Goswami, Venkateshwar Madka and Chinthalapally V. Rao
Targets 2025, 3(1), 4; https://doi.org/10.3390/targets3010004
“Colorectal Cancer: Epidemiology, Risk Factors, and Prevention”
by Gholamreza Roshandel, Fatemeh Ghasemi-Kebria and Reza Malekzadeh
Cancers 2024, 16(8), 1530; https://doi.org/10.3390/cancers16081530
“Symptom Burden and Time from Symptom Onset to Cancer Diagnosis in Patients with Early-Onset Colorectal Cancer: A Multicenter Retrospective Analysis”
by Victoria A. Baronas, Arif A. Arif, Eric Bhang, Gale K. Ladua, Carl J. Brown, Fergal Donnellan, Sharlene Gill, Heather C. Stuart and Jonathan M. Loree
Curr. Oncol. 2024, 31(4), 2133-2144; https://doi.org/10.3390/curroncol31040158

|
“Recent Advances in Surgical Strategies for Managing Metastatic Colorectal Cancer” |
“Novel Strategies in the Prevention/Treatment of Colorectal Cancer: 2nd Edition” |
![]() |
![]() |
|
“Molecular Mechanisms and Therapeutic Strategies of Colorectal Cancer” |
“Gut Microbiota and Inflammation in Colorectal Tumor Development and Progression” |
![]() |
![]() |

![]() |
![]() |
![]() |
2 April 2026
Recruiting Editorial Board Members for Targets
Targets (ISSN: 2813-3137) is a peer-reviewed, international, scientific, and open access journal published online by MDPI. It aims to publish high-quality articles in the field of chemistry, especially chemical measurement science, biology, material science, pharmacy, clinical diagnostics, molecular medicine, and biomedicine. Its objects involve the weak interaction or recognition of chemical, biological, and drug molecules, bioprobes, nanomaterials, nanostructures, and cells, as well as related research methodologies and biomedical applications, such as sensing, imaging, and targeted therapy. The measurement methods include electrochemistry, fluorescence, luminescence, Raman spectroscopy, mass spectroscopy, etc., and the therapeutic approaches include chemotherapy, photoresponsive therapy, gene therapy, immune therapy, etc. Targets also covers signal amplification strategies based on the weak interaction of target analysis and stimuli-responsive therapeutic approaches.
In order to adapt to the development of the scale of the journal and ensure its sustainability, we are now recruiting for the position of Editorial Board Members of Targets.
Recruitment:
Editorial Board Members will hold the position for two years, with the possibility of renewal for a second term.
Eligibility criteria of applicants:
- Must have completed their doctorate/PhD degree;
- Must have published impactful work in the fields of chemical measurement science, biology, material science, pharmacy, clinical diagnostics, molecular medicine and biomedicine;
- Must currently (at the time of application) be serving as an associate professor or professor in academia.
The main responsibilities of Editorial Board Members are as follows:
- Pre-screening and making decisions on new submissions related to their research interests;
- Helping to edit or supervising a Special Issue on a topic related to your expertise;
- Helping to promote the journal among your peers or at conferences;
- Attending board meetings to suggest journal development strategies;
- Reviewing manuscripts;
- Recommending senior scholars to join our editorial team.
The benefits of becoming an Editorial Board Member include the following:
- A certificate recognizing you as an Editorial Board Member;
- Travel grants, offered to Editorial Board Members who make significant contributions to the journal;
- Enjoy additional sponsorships for conferences organized by Editorial Board Members;
- The opportunity to publish one paper per year free of charge in our journal and potential discounts for the authors of papers invited by you;
- Organizing or promoting your own conferences using our SciForum platform;
- An expanded research network providing new insights, collaborations, and opportunities for future research projects.
To apply for this position, recommend potential candidates, or request further information, please contact the Targets Editorial Office via targets@mdpi.com with the following two files attached:
- A full academic CV;
- A short cover letter that details your interest and enthusiasm for this position.
You can find the journal’s aims and scope on our homepage: https://www.mdpi.com/journal/targets/about. For more information about the Editorial Board team, please see the following link: https://www.mdpi.com/journal/targets/editors.
We look forward to welcoming new members to help shape the future of Targets.
Targets Editorial Office
2 April 2026
2026 Tu Youyou Award—Open for Nominations
We are delighted to announce that nominations are now open for the 2026 Tu Youyou Award. Named after Nobel Laureate Tu Youyou, whose discovery of artemisinin has saved millions of lives, this award recognizes researchers whose work advances the fields of natural products chemistry and medicinal chemistry, while also contributing to human health.
Prize
– CHF 100,000;
– A medal;
– A certificate.
The monetary prize will be shared equally should there be multiple recipients.
Who May Be Nominated?
– Scientists with outstanding achievements and contributions in the fields of natural products chemistry and medicinal chemistry.
Nominees must be individuals; team or group nominations are not permitted. Nominations are valid only for the current award cycle.
Who May Submit a Nomination?
– The director of the nominee’s host research institution or recognized scientists within the field.
Self-nominations will not be considered.
Nomination Materials
– A biographical sketch;
– A detailed description of the nominee’s contributions;
– 5–10 representative academic publications;
– A list of academic honors, awards, and funded projects;
– A nomination letter signed by two nominators.
How to Submit?
Submit nominations online via the following link: https://tuyouyouprize.org/nomination
Important Dates
– Nomination Deadline: 31 October 2026
– Winner Announcement: March 2027
For further information, please visit the Tu Youyou Award website (https://tuyouyouprize.org/). For any inquiries, please contact the Tu Youyou Award Team at tuyouyouaward@mdpi.com.
31 March 2026
MDPI INSIGHTS: The CEO’s Letter #33 - 2025 Annual Report, Preprints.org, IWD, Recapping Viruses 2026 & Romania Salon
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts

Scaling Open Access with Integrity: MDPI Annual Report 2025
I am pleased to share the release of MDPI’s 2025 Annual Report, reflecting our continued progress as one of the world’s leading open access publishers. The report highlights not only our growth, but also the continued evolution of our publishing model and our commitment to quality, transparency, and collaboration.
You can explore the full report here: https://mdpi-res.com/data/mdpi_annual_report_2025_0401.pdf?1775045421
Or visit the interactive page: https://www.mdpi.com/annual-report-2025/
A Year of Growth and Responsibility
2025 was a year of significant growth for MDPI. We received over 669,000 manuscript submissions, the highest in our history, while maintaining a rejection rate above 60%, reinforcing our commitment to both scale and quality.
We published 261,576 peer-reviewed open access articles across a portfolio of 500 journals, supported by a global community of more than 68,000 Editorial Board Members and 209,000 reviewers.
Scaling with Integrity
Growth alone is not the objective; how we grow matters.
Our 2025 Annual Report, Scaling Open Access with Integrity, reflects our continued focus on building the systems and processes that support reliable and trustworthy publishing. As submission volumes increase globally, so too does the importance of robust editorial workflows, research integrity frameworks, and the infrastructure required to support them.
In 2025, we continued to invest in:
- Research integrity and quality assurance processes
- Editorial support and reviewer engagement
- Transparency across the publishing workflow
These efforts ensure that scale does not come at the expense of rigor, but rather reinforces it.
Validation Through Indexing and Visibility
As MDPI continues to grow, validation of quality remains essential.
In 2025, the number of MDPI journals indexed in the Web of Science Core Collection increased from 298 to 329, while Scopus coverage reached 355 journals, including 45 new acceptances. Coverage in major biomedical databases (PMC/Medline/PubMed) expanded to 95 journals, and indexing in Ei Compendex increased significantly.
These milestones reflect the strength of our editorial processes and the trust placed in our journals by independent indexing bodies.
Importantly:
- 96% of all MDPI articles are indexed in Web of Science databases
- More than 1.75 million articles are indexed, with an average of 13 citations per article
Recognition through Journal Citation Reports also continues to grow:
- 298 journals received Impact Factors
- 65% ranked in the top half of their categories
- 61 journals achieved top-quartile positions
These developments demonstrate that growth and quality are advancing together, supported by strong editorial oversight and consistent performance across our journal portfolio.
Strengthening Partnerships and Community
Open access is a collaborative endeavor.
In 2025, we expanded our institutional partnerships to more than 1,000 IOAP agreements, helping simplify publishing for researchers and institutions worldwide.
We also hosted 60 in-person conferences and virtual events, bringing together more than 28,000 participants to exchange ideas, share research, and strengthen connections across the global scientific community.
At the heart of everything we do is this community of authors, editors, reviewers, and partners who make open science possible.
Looking Ahead
Open access continues to move toward becoming the standard model for sharing research globally. With that growth comes increased responsibility.
Our focus moving forward is to continue building a publishing ecosystem that is:
- Collaborative, to serve the research community
- Rigorous, to ensure quality
- Transparent, to support trust
- Scalable, to meet global demand
We believe that open access, when combined with strong editorial standards and integrity, is the most effective way to accelerate scientific progress.
Thank you to all the scholarly community who collaborated with us and our MDPI staff for your continued dedication and contributions in making 2025 a successful year.
Impactful Research

Celebrating Ten Years of Preprints.org: Accelerating Open Research
In 2026, MDPI’s preprints server Preprints.org marked its 10th anniversary as a platform dedicated to accelerating the dissemination of research. Since its launch, Preprints.org has grown into a global platform that hosts more than 120,000 preprints contributed by hundreds of thousands of researchers worldwide, generating tens of millions of views and downloads and demonstrating the value of sharing research openly and rapidly.
At MDPI, we are proud to celebrate ten years of Preprints.org supporting the mission of open science. Over the past decade, we have seen how early sharing of research can accelerate collaboration and help ideas move more quickly from discovery to impact.
The Evolution of Preprints
While Preprints.org launched in 2016, the idea behind it has deeper roots. The concept of rapid research dissemination has existed for decades, with early preprint servers showing how open sharing can accelerate scientific progress.
Over the past decade, preprints have become an increasingly important part of scholarly communication. Researchers across disciplines are looking at faster ways to share their discoveries, exchange ideas, and receive feedback from the global scientific community.
Preprints in a Growing Research Ecosystem
The global preprint landscape has expanded significantly over the past decade, with multiple platforms serving different research communities. The figure below (sourced from James Butcher newsletter), based on data from Dimensions (Digital Science), shows the growth of preprint outputs across several major platforms over time.

Among these platforms, arXiv (the pioneering preprint server) has experienced great growth in recent years. At the same time, other platforms have continued to expand their reach across disciplines, capturing increasing global interest in early research sharing.
Preprints.org contributes to this evolving ecosystem by providing a multidisciplinary platform that works in synergy with academic journals, helping researchers bridge the gap between rapid dissemination and the formal publication process.
Celebrating the First Decade
To commemorate this milestone, Preprints.org launched a 10th Anniversary celebration hub highlighting the impact of preprints and the researchers who contribute to them.

One of the central initiatives is the Popular Preprints of the Decade Award, recognizing influential preprints published between 2016 and 2026 across multiple research fields. Through community voting, the award will recognize research that has generated high engagement and visibility within the global research community.
Looking Ahead: The Next Decade of Preprints
As research communication continues to evolve, preprints will continue to play an important role in enabling faster collaboration, improving transparency, and expanding access to knowledge. The next decade may bring further integration between preprint platforms and journals, new tools for discovery and evaluation, and greater global participation in open science.
At MDPI, we remain committed to supporting researchers through platforms that encourage the open exchange of ideas. The success of Preprints.org over the past ten years reflects the engagement and trust of the global research community – authors, readers, reviewers, and collaborators who believe in the value of sharing knowledge openly.
Congratulations to everyone involved in the development and growth of Preprints.org over the past decade!
Inside MDPI

Beyond International Women’s Day: Supporting Women in Research
International Women’s Day (IWD) offers an opportunity to recognize the achievements of women around the world and reflect on how we can continue building a more inclusive future. In research and academia, this conversation carries particular importance, as scientific progress depends on diverse perspectives, and supporting women in science is essential to strengthening the global research ecosystem.
For MDPI, IWD is an opportunity to celebrate the achievements of women in research and highlight the initiatives, conversations, and collaborations that help support researchers across disciplines and career stages.
Highlighting Women in Science Across MDPI
This year, MDPI marked International Women’s Day with a global campaign highlighting research, awards, and perspectives that support women in science. Throughout the week, our teams shared content across MDPI’s social media channels sharing the work of women researchers and encouraging engagement across the academic community.

As part of this initiative, MDPI published several blog articles exploring important themes related to gender equity in research. One article, Give Support, Gain Progress: Retaining Women in Science, discusses the importance of mentorship, institutional support, and inclusive research environments in helping women build sustainable scientific careers.
Another featured article, Bridging the Gap in Women’s Health Research, highlights the ongoing need to address disparities in health research and ensure that women’s health receives the scientific attention and investment it deserves.
These topics capture the notion that supporting women in science benefits not only individual researchers but the entire scientific community. When researchers from diverse backgrounds can contribute their perspectives and ideas, the scope and impact of scientific discovery expand.
Creating Spaces for Dialogue
Beyond online content, MDPI is also supporting conversations about women in research through community engagement.

On 10 March, MDPI UK hosted the “Women in Research” event, bringing together researchers and professionals to share experiences and discuss the opportunities and challenges women face throughout their scientific careers. Events like these are an opportunity for open dialogue, mentorship, and networking to create more inclusive research communities.
Looking Beyond a Single Day
While IWD is an important moment of recognition, progress requires ongoing effort.
Supporting women in research involves many forms of engagement: from mentorship and collaboration to creating inclusive environments in which diverse voices are heard and valued. Publishers, institutions, and researchers all play a role in building this ecosystem.
At MDPI, we remain committed to supporting the global research community and to promoting open access publishing as a foundation for accessible and inclusive knowledge-sharing.
As we reflect on IWD this year, we recognize the many women who contribute to research as authors, reviewers, editors, mentors, and educators; we also recognize the impact they continue to have on the advancement of science. The influence of women in research extends far beyond a single day of recognition, reminding us that supporting them is a commitment that continues throughout the year.
Coming Together for Science

Highlights from Viruses 2026 – New Horizons in Virology (11–13 March)
Through 11–13 March, we successfully delivered the Viruses 2026 – New Horizons in Virology MDPI conference in Barcelona, bringing together an international community of researchers, editors, and partners dedicated to advancing the field of virology.
Conference Highlights
Viruses 2026 in numbers:
- 198 total registrations, with 171 attendees on site
- 233 submissions, with 122 accepted
- 42 short talks, 9 flash talks, and 80 posters
- 13 invited speakers and 1 keynote speaker

The strong level of participation and quality of submissions once again demonstrate the relevance of the Viruses community.
A standout moment was the keynote lecture by Dr. Ho, which also attracted an NBC documentary film crew, highlighting the broader impact of the research being presented.
Scientific Programme
The conference programme covered areas across modern virology, including viral replication, pathogenesis, immunology, and public health. Sessions explored topics on antiviral therapeutics and vaccines, innate immunity, virus–host interactions, and the structure and mechanisms of virus replication.
Together, these discussions highlighted both the fundamental biology of viruses and the translational challenges of addressing emerging infectious diseases, reflecting the breadth and continued importance of virology research in a global context. The programme also included a sponsored workshop on research data management in virology, further emphasizing the importance of data practices in advancing the field.
Thank You
Feedback from participants has been very positive, and I would like to thank the Conference team for the organization and delivery of this year’s event.

Thank you to our Viruses journal team and all colleagues involved behind the scenes in supporting the delivery of the event. As noted by Dr. Eric Freed (EiC of Viruses), the success of this edition gives us strong momentum as we look ahead to the next conference in 2028, with opportunities to further expand participation and engagement.
Closing Thoughts

Recap from MDPI Romania Salon in Cluj-Napoca (24 March)
On 24 March, we had the opportunity to meet with members of the Romanian research community in Cluj-Napoca at our MDPI Romania Salon. The event was a space for presentations, open discussion, and the exchange of perspectives on publishing and the research landscape in Romania.

We welcomed 39 participants, including 27 researchers from institutions across Romania, representing cities such as Cluj-Napoca, Timișoara, and Reșița. Among them were Editorial Board Members, Associate Editors, and Guest Editors, all of whom play an important role in collaborating with MDPI and shaping the quality and direction of academic publishing.
|
|
|
|
A Shared Commitment to Research Excellence
These events reflect MDPI’s commitment to connecting with and supporting researchers by means of transparency, dialogue, and collaboration. During the day, MDPI colleagues shared a series of presentations covering different parts of our publishing ecosystem:
- MDPI’s presence in Romania – Anamaria Vartolomei (Journal Relationship Specialist (JRS), Section Managing Editor (ME))
- MDPI’s performance, growth, and impact in Romania – Stefan Tochev (CEO)
- Academic services, initiatives, and projects supporting researchers – Ioana Preda (JRS, Section ME)
- Best practices and standards in publication ethics – Lavinia Rogojina (Research Integrity Manager)
- Panel session on ethics, AI, and peer review – Lavinia Rogojina, Ioana Preda, Doris Larisa Albu (JRS, Section ME), Cristina Georgiana Spelmezan (JRS, Section ME)
- Closing remarks – Lavinia Dumitrela Cozma (Operations Manager, Section ME)

Feedback from participants was very positive, particularly regarding the quality of discussions, the relevance of the topics, and the opportunity to engage directly with MDPI colleagues. What stood out most was the openness of the discussion. These events are important not only for the purposes of presenting what we do, but also as an opportunity to listen, understand concerns, and continue to build alignment with the research community.
Romania and the Growth of Open Access Publishing
The Romanian research landscape continues to show growth in open access (OA) publishing.
In 2025:
- 72% of all publications in Romania were published as OA
- Of these, 74% were Gold Open Access
Over the past five years, Romania has produced more than 109,000 publications, with approximately 71% available openly, highlighting a sustained shift toward accessibility and knowledge-sharing.
Within this landscape, MDPI continues to play a significant role:

- MDPI is the leading OA publisher in Romania, contributing 42% of all OA publications in 2025
- More than 37,000 articles have been published with MDPI by Romanian institutions since 1996
- This figure includes over 7,500 publications in 2025 alone
- More than 400 Editorial Board Members from Romania collaborate with MDPI across disciplines
These trends show the growth of OA and the strength of collaboration between MDPI and the Romanian research community.
Looking Ahead
As academic publishing continues to evolve, maintaining open and transparent communication with researchers is essential. Events such as our Salons and Summits provide great opportunities to exchange perspectives and to build trust and collaboration.
Thank you to all participants who joined us in Cluj, and to our teams in Romania for delivering a successful event. A special thank-you to Alina-Florina Agafitei (Marketing Specialist) for her care and attention to detail in delivering the Salon.
Chief Executive Officer
MDPI AG



















































































